| Kathy Tahereh Hosseinyar, | |
|
3802 Culver Ctr, Culver City, CA 90232-3303 | |
| (310) 837-2122 | |
| Not Available |
| Full Name | Kathy Tahereh Hosseinyar |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 3802 Culver Ctr, Culver City, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164790275 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 66043 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kathy Tahereh Hosseinyar, 3802 Culver Ctr, Culver City, CA 90232-3303 Ph: () - | Kathy Tahereh Hosseinyar, 3802 Culver Ctr, Culver City, CA 90232-3303 Ph: (310) 837-2122 |
News Archive
There is currently no cure for Diabetes, Alzheimer's and Dementia but they can be treated and prevented. Allegiance Equity developed CinGx™ as a safe and effective treatment for these diseases.
Researchers from Memorial Sloan-Kettering Cancer Center (New York, NY) have found that tumor "separation surgery" followed by high-dose hypofractionated stereotactic radiosurgery (SRS) or high-dose single-fraction SRS is safe and effective in controlling spinal metastases regardless of the radiosensitivity of the particular tumor type that has invaded the spine.
A recent study, published in the January issue of Mayo Clinic Proceedings, demonstrates that in elderly patients undergoing hip fracture repair under spinal anesthesia with propofol sedation, the prevalence of delirium can be decreased by 50 percent with light sedation, compared to deep sedation.
Recent investigations of medications, diet and the molecular understanding of prostate cancer are defining potential prevention strategies for the disease, and herald a new stage in the management of this cancer, according to a new review.
Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted approval for the expansion of the company's pneumococcal conjugate vaccine, Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]), for use in older children and adolescents aged 6 years through 17 years for active immunization for the prevention of invasive disease caused by the 13 Streptococcus pneumoniae serotypes contained in the vaccine.
› Verified 4 days ago
Stephen Lem, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6299 Bristol Pkwy, Culver City, CA 90230 Phone: 310-641-4426 | |
Naseem Ali, REGISTERED PHARMACIS Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3836 Keystone Ave Apt 1, Culver City, CA 90232 Phone: 310-904-8283 | |
Dr. Shadi Loloee, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6000 Sepulveda Blvd Ste 2250, T-2632, Culver City, CA 90230 Phone: 310-754-4615 Fax: 310-754-4624 | |
Jessica Jones, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3802 Culver Ctr, Culver City, CA 90232 Phone: 310-837-2122 | |
Sheryl Denise Williams, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11096 Jefferson Blvd, Culver City, CA 90230 Phone: 310-397-3931 Fax: 310-397-0381 | |
Carol Nakayama Inatomi, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11030 Jefferson Blvd, Culver City, CA 90230 Phone: 310-398-8044 Fax: 310-398-1505 |